A Bitter Pill: Why Big Pharmas Era of Big Profits May Be Expiring

Pharmaceutical companies, pressured by buyers to lower drug prices, find their high profit margins threatened.

Click to Read Post


PUBLISHED: August 8, 2019

Get Our Latest Posts Delivered Right To Your Inbox.

More Like This

A Prescription for Growth? Why Pharma Companies Are Testing New Tactics to Refill Their Drug Pipelines

Many pharmaceutical companies are shifting away from large acquisitions, instead opting to buy smaller firms with riskier, earlier-stage drug candidates. Others are experimenting with new strategies altogether.
Read Blog

Why Subscription Revenue is Lifting the Enterprise Software Industry and Investor Expectations

Selling software as a service instead of a product has been a boon for enterprise software companies. But will their growth translate to high profits?
Read Blog

Faster Fashion: Why Being Quick to Market Matters More Now for Apparel Companies

To regain market share lost to nimble competitors, established footwear and apparel brands are taking steps to accelerate design, production, and sales.
Read Blog
  Back To Top